Your new post is loading...
Fresenius Medical Care is a German company with subsidiaries worldwide that manufactures and distributes the dry acid GranuFlo and its liquid counterpart NaturaLyte. Prior to the March 29 2012 Recall of these two substances, GranuFlo...
Via Matthew A. Dolman
An internal memorandum was sent by Fresenius to its own dialysis centers warning that 941 patients had suffered heart attacks shortly after receiving treatments containing Granuflo. The memo outlines the danger of alkalosis (decreased acidity in the blood) and raised bicarbonate levels. It specifically states, “borderline elevated pre-dialysis bicarbonate levels and overt alkalosis are significantly associate with [a] 6 to 8 fold greater risk of [cardiopulmonary] arrest and sudden cardiac death in the dialysis facility.” The memo clearly proves that Fresenius was aware that their product was causing a massive increase in the risk of heart attacks and other deadly cadiovascular problems such as stroke
(read more by clicking on the article)